Teva Offers Update On Operations In Israel :: Generics Bulletin
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
Teva is back: returned to being the largest company in terms of market value in Israel :: Israeli Financial News - The Israeli Economic World
Teva Pharma plans to cut about 5,000 employees
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva to build new headquarters in Tel Aviv - Globes
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva reaches $21m settlement with Rhode Island over opioid-related claims | The Times of Israel
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Teva to Close Missouri Plant, Report Says | Ctech
Teva headquarters hi-res stock photography and images - Alamy
Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive | Fierce Pharma
Teva Pharmaceutical says 48 states have agreed to its opioid settlement (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Teva Pharmaceutical Industries – The Forward
Teva Pharmaceutical Company Logo Editorial Stock Photo - Image of background, glaxosmithkline: 89310878
Principle - leveraging the power of brand for Teva
Teva Pharmaceuticals Office Photos
Teva will move North American HQ to New Jersey - Kansas City Business Journal
Teva USA
Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to North Jersey - WHYY
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
